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Background: Obesity is associated with increased health risk and has been associated with alterations in bacterial gut
microbiota, with mainly a reduction in Bacteroidetes, but few data exist at the genus and species level. It has been reported that
the Lactobacillus and Bifidobacterium genus representatives may have a critical role in weight regulation as an anti-obesity effect
in experimental models and humans, or as a growth-promoter effect in agriculture depending on the strains.
Objectives and methods: To confirm reported gut alterations and test whether Lactobacillus or Bifidobacterium species found
in the human gut are associated with obesity or lean status, we analyzed the stools of 68 obese and 47 controls targeting
Firmicutes, Bacteroidetes, Methanobrevibacter smithii, Lactococcus lactis, Bifidobacterium animalis and seven species of Lactobacillus
by quantitative PCR (qPCR) and culture on a Lactobacillus-selective medium.
Findings: In qPCR, B. animalis (odds ratio (OR)¼0.63; 95% confidence interval (CI) 0.39–1.01; P¼0.056) and M. smithii
(OR¼0.76; 95% CI 0.59–0.97; P¼0.03) were associated with normal weight whereas Lactobacillus reuteri (OR¼1.79; 95% CI
1.03–3.10; P¼0.04) was associated with obesity.
Conclusion: The gut microbiota associated with human obesity is depleted in M. smithii. Some Bifidobacterium or Lactobacillus
species were associated with normal weight (B. animalis) while others (L. reuteri) were associated with obesity. Therefore, gut
microbiota composition at the species level is related to body weight and obesity, which might be of relevance for further studies
and the management of obesity. These results must be considered cautiously because it is the first study to date that links
specific species of Lactobacillus with obesity in humans.
International Journal of Obesity (2012) 36, 817–825; doi:10.1038/ijo.2011.153; published online 9 August 2011
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Introduction
Obesity, defined as a body mass index (BMI) over 30kgm
 2( r e f .1 )
and a massive expansion of fat, is related to a significantly
increased mortality and is a risk factor for many diseases,
including diabetes mellitus, hypertension, respiratory disorders,
ischemic heart disease, stroke and cancer.
2,3 Obesity can be
considered as a transmissible disease because maternal obesity
predisposes children to adulthood obesity.
4 Its prevalence is
increasing steadily among adults, adolescents and children,
and has doubled since 1960; and obesity is now considered
a worldwide epidemic as, for example, over 30% of the
population of North America is obese. The WHO data
indicate that obesity currently affects at least 400 million
people worldwide and 1.6 billion are overweight. The WHO
further projects that by 2015, B2.3 billion adults will be
overweight and more than 700 million will be obese.
5
The causes behind the obesity epidemic appear to be
complex and involve environmental, genetic, neural and
endocrine origins.
6
More recently, obesity has been associated with a specific
profile of the bacterial gut microbiota, including a decrease
Received 24 November 2010; revised 27 June 2011; accepted 2 July 2011;
published online 9 August 2011
Correspondence: Professor D Raoult, Unite ´ des Rickettsies, URMITE -CNRS
UMR 6236 IRD 198, IFR 48, Faculte ´ de Me ´decine, Universite ´ de la
Me ´diterrane ´e, 27 Bd Jean Moulin, Marseille, 13005 France.
E-mail: Didier.raoult@gmail.com
International Journal of Obesity (2012) 36, 817–825
& 2012 Macmillan Publishers Limited All rights reserved 0307-0565/12
www.nature.com/ijoin the Bacteroidetes/Firmicutes ratio
7–10 and a decrease in
Methanobrevibacter smithii, the leading representative of the
gut microbiota archaea.
11 Since these pioneering studies,
significant associations were found between the increase of
some bacterial groups and obesity (Lactobacillus,
12 Staphylo-
coccus aureus,
13–15 Escherichia coli,
15 Faecalibacterium praus-
nitzii
16). Conversely, other groups have been associated with
lean status, mainly belonging to the Bifidobacterium
genus.
11,13–16 To date, controversial studies make it clear
that the connection between the microbiome and excess
weight is complex.
17
As many probiotic strains of Lactobacillus and Bifidobacterium
are marketed in products for human consumption, altering
the intestinal flora
18 and stimulating indigenous lactobacilli
and bifidobacteria strains,
19 we hypothesized that wide-
spread ingestion of probiotics may promote obesity by
altering the intestinal flora.
20–22 However, this remains
controversial.
23,24 In a first step to elucidate the interactions
between probiotics for human consumption and obesity,
only a few studies have compared the obese and lean subjects
by focusing on the Lactobacillus and Bifidobacterium genera
at the species level
13,16 and they have not been able to
demonstrate significant differences probably because of a
too small sample size. As a result, by increasing the sample
size, we analyze the composition of the digestive microbiota
for Firmicutes, Bacteroidetes, the archaea M. smithii,
Lactobacillus genus, L. lactis, and explore the relationships
between seven selected species of Lactobacillus and one
species of Bifidobacterium, used elsewhere in marketed
probiotics for human consumption and obesity.
Materials and methods
Ethics, participants and samples
All aspects of the study were approved by the local ethics
committee ‘Comite ´ d’e ´thique de l’IFR 48, Service de
Me ´decine Le ´gale’ (Faculte ´ de Me ´decine, Marseille, France)
under the accession number 10–002, 2010. Only verbal
consent was necessary from patients for this study. This is
according to the French bioethics decree Number 2007–
1220, published in the official journal of the French
Republic. Obese patients, as defined by a BMI430kgm
 2
(BMI: weight over height squared (kgm
 2)), were selected
from two endocrinology units (Hopital La Timone and
Hopital Sainte Marguerite, Marseilles, France) from a group
of patients attending the clinic for excessive body weight.
BMI provides the most useful population-level measure of
overweight and obese, as it is the same for both sexes and for
all ages of adults.
5 However, it may not correspond to the
same degree of fatness in different individuals (The Y-Y
paradox).
25 Control subjects were healthy volunteers over 18
years of age with BMIs between 19 and 25kgm
 2. Only a few
patients had participated in the previous study conducted by
our laboratory.
12 The control subjects were predominantly
Caucasian and were approached in different geographical
locations using a snowball approach. This approach was
helpful in making the period of recruitment of cases and
controls comparable. The exclusion criteria included the
following: non-assessable BMI value, BMIo19kgm
 2,
BMI425kgm
 2 and o30kgm
 2, gastric bypass, history of
colon cancer, bowel inflammatory diseases, acute or chronic
diarrhea in the previous 4 weeks and antibiotic administra-
tion o1 month before stool collection. Clinical data (gender,
date of birth, clinical history, weight, height and antibiotic
use) were recorded using a standardized questionnaire. The
samples, collected using sterile plastic containers, were
transported as soon as possible to the laboratory and frozen
immediately at  801C for later analysis. For Firmicutes,
Bacteroidetes, M. smithii and Lactobacillus species, analyses
were first performed on the whole population and then after
exclusion of common subjects with our previous study.
12
Analysis of gut microbiota
Culture on specific Lactobacillus medium (LAMVAB
medium). After thawing at room temperature, 100mg of
stool was suspended in 900ml of cysteine–peptone–water
solution
26 and homogenized. A serial dilution was under-
taken in phosphate buffered saline. Samples diluted to 1/10
and 1/1000 were inoculated using a 10ml inoculation loop
on LAMVAB medium.
27 After a 72-hour incubation in jars
(AnaeroPack, Mitsubishi Gas Chemical America, Inc., New
York, NY, USA) in an anaerobic atmosphere (GasPak EZ
Anaerobe, Becton Dickinson, Heidelberg, Germany) at 371C,
the number of morphotypes were identified and 1–4 colonies
per morphotype were placed on four spots of an MTP 384
Target plate made of polished steel (Bruker Daltonics GmbH,
Bremen, Germany) and stored in trypticase cases in soy
culture medium (AES, Bruz, France).
Lactobacillus strain collection and MALDI-TOF spectra
database. The Lactobacillus strain collection of our labora-
tory has been completed by the strains from the Pasteur and
DSMZ collections, and reference spectra have been created
from those missing in the Bruker database. Bacterial identifica-
tion was undertaken with an Autoflex II mass spectrometer
(Bruker Daltonik GmbH). Data were automatically acquired
using Flex control 3.0 and Maldi Biotyper Automation
Control 2.0. (Bruker Daltonics GmbH). Raw spectra, ob-
tained for each isolate, were analyzed by standard pattern
matching (with default parameter settings) against the
spectra of species used as a reference database. An isolate
was regarded as correctly identified at the species level when
at least one spectrum had a score X1.9, and one spectrum
had a score X1.7.
28 The reproducibility of the method was
evaluated by the duplicate analysis of 10 samples.
Quantitative real-time PCR for M. smithii, Bacteroidetes,
Firmicutes and Lactobacillus genus. DNA was isolated from
stools as described in Dridi et al.
29 The purified DNA samples
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until analysis. Real-time PCR was performed on a Stratagene
MX3000 system (Agilent, Santa Clara, CA, USA) using
QuantiTect PCR mix (Qiagen, Courtaboeuf, France) as
described previously.
12
Quantitative real-time PCR specific for Lactococcus lactis,
Bifidobacterium animalis and seven Lactobacillus species. The
primer and probe sequences were located on the Tuf
(elongation factor Tu) gene. The Tuf gene from the
Lactobacillus strains, reported in Supplementary Table 1, were
sequenced and compared, where possible, to the sequence
reported in Genbank as described in Supplementary Text 1.
All of these sequences were compared by ClustalX (1.8;
http://www.clustal.org) using global-multiple sequence
alignment by the progressive method. A distance is calcu-
lated between every pair of sequences and these are used to
construct the phylogenetic tree, which guides the final
multiple alignment. The scores are calculated from separate
pairwise alignments using the dynamic programming
method. A consensus sequence was obtained and compared
with the Tuf sequences of Lactobacillus acidophilus, Lactoba-
cillus casei-paracasei, Lactobacillus plantarum, Lactobacillus
reuteri, Lactobacillus gasseri, Lactobacillus fermentum and
Lactobacillus rhamnosus, Bifidobacterium animalis and Lacto-
coccus lactis, and sequences of primers and probes of highly
specific real-time PCR were established. The primer and
probe sequences are reported in Supplementary Table 2. The
Lactobacillus strain-specific detection proceeded in duplex
real-time PCR: L. acidophilus (FAM) and L. casei/paracasei
(VIC), L. plantarum (FAM) and L. reuteri (VIC), L. gasseri (FAM)
and fermentum (VIC), and L. rhamnosus (FAM). B. animalis
(VIC) and Lactococcus lactis (FAM) detection utilized simplex
real-time PCR. The duplex real-time PCR was executed as
described above and in Armougom et al.
12 The specificity was
tested on the DNA of the reference strains reported in
Supplementary table 1. The stool-purified DNA was analyzed
in samples that were pure, diluted at 1/10, and diluted at 1/
100 to confirm the absence of inhibitors. Negative controls
were included on each plate. The different lactobacilli, B.
animalis and Lactococcus lactis were quantified using a
plasmid standard curve from 10
7–10 copies per assay.
Statistical Analysis
First, the results of Lactobacillus-specific culture and quanti-
tative PCR (qPCR) were compared in the two groups (obese
and control group) using the Fisher’s exact test when
comparing proportions, and the Mann–Whitney test when
comparing bacterial concentrations. A difference was con-
sidered statistically significant when Po0.05. In order to
identify which qPCR bacterial groups (Bacteroidetes, B. animalis,
Lactococcus lactis, L. acidophilus, L. casei/paracasei, L. fermentum,
L. gasseri, L. plantarum, L. reuteri, L. rhamnosus) was most
associated with the likelihood of being obese while taking into
account possible confounders like age or gender, a logistic
regression model was used. Variables with a liberal Po0.20 in
the univariate logistic regression analysis were considered
eligible for the multiple logistic regression analyses.
30 A
secondary analysis based on logistic regression analysis was
used to identify which culture variables (Lactobacillus species
concentration) where associated with obesity. Data analyses
were conducted using SPSS v.9.0 (SPSS Inc., Chicago, IL, USA).
Results
Patients
In total, 115 subjects (68 obese patients and 47 controls)
were included. Thirteen obese subjects and nine controls
were part of the previous study conducted in our labora-
tory.
12 The two populations were homogeneous in sex and
height, but not in age (Table 1).
Culture
In total, 68 obese and 44 controls samples were analyzed.
The number of positive samples was greater among the
controls vs obese (32/44 vs 30/68, Fisher’s exact test,
P¼0.002). For positive samples, the concentration was not
significantly different between obese subjects and controls,
respectively (median 4.15 (interquartile range 4–6) vs 5.2
(4–6) log10 CFUml
 1, Mann–Whitney test, P¼0.93). The
proportion (Table 2) and non-parametric quantitative com-
parison of the concentration of Lactobacillus species between
obese subjects and controls has been achieved for the species
present in at least six individuals. L. paracasei was found
more frequently in controls (17/44 vs 10/68, Fisher’s exact
test, P¼0.004). L. reuteri was found more frequently in obese
patients (6/68 vs 1/44, Fisher’s exact test, P¼0.15), although
this was not significant. L. plantarum was found only in
Table 1 Baseline characteristics
Obese (n¼68) Controls (n¼47) P (obese vs controls)
Age 50.5±14.4 42.6±17.5 0.01
a
Male sex 31 (45.6%) 21 (51.2%) 0.35
b
Body mass index 43.6±7.8 22.1±1.8 o0.0001
a
aMann–Whitney test.
bFisher’s exact test
Table 2 Results of Lactobacillus-specific culture
Obese (n¼68) Controls (n¼44) P-value
a
L. paracasei 10 (14.7%) 17 (38.6%) 0.004
L. plantarum 0 (0%) 8 (18.2%) 0.0004
L. reuteri 6 (8.8%) 1 (2.3%) 0.16
L. rhamnosus 3 (4.4%) 4 (9.1%) 0.27
L. ruminis 3 (4.4%) 4 (9.1%) 0.27
L. salivarius 5 (7.4%) 2 (4.5%) 0.43
aSpecies present in at least six individuals. Fisher’s exact test.
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Quantitative comparison found higher levels of L. paracasei
and L. plantarum in controls (Mann–Whitney test, P¼0.005
and P¼0.0004, respectively), while L. reuteri was higher in
the obese subjects; however, this was not significant (Mann–
Whitney test, P¼0.14) (Figure 1). Variables eligible for the
final logistic regression model were L. paracasei, L. reuteri,
L. plantarum, L. brevis, L. fermentum and age. The final
multiple logistic regression model showed that after adjust-
ment for age, only L. paracasei was significantly associated
with lean status (odds ratio¼0.79; 95% confidence interval
0.64–0.97; P¼0.03).
Firmicutes, Bacteroidetes, M. smithii and Lactobacillus
species-specific qPCR
M. smithii was found more frequently in controls (40/
45(89%) vs 50/67(75%), Fisher’s exact test, P¼0.05). The
analysis did find a lower concentration of M. smithii in
obese subjects (Mann–Whitney test, P¼0.002; Table 3) and
a higher concentration of Lactobacillus (Mann–Whitney
test, P¼0.04). Bacteroidetes was found in lower concen-
tration in obese, but this result was not significant (Mann–
Whitney test, P¼0.25) (Figure 2). The same results were
found after the exclusion of the common subjects from
our previous study (Mann–Whitney test; higher level of
Lactobacillus genus in obese people, P¼0.026; lower level
of M. smithii, P¼0.008 and lower level of Bacteroidetes,
P¼0.09).
Bifidobacterium–Lactococcus–Lactobacillus species-specific
qPCR
The different Bifidobacterium–Lactococcus–Lactobacillus spe-
cies-specific real-time PCRs were tested for their specificity
against purified DNA of the strains reported in Supplemen-
tary Table 1. The different real-time PCR systems were tested
for their sensitivity and we obtained a cycle threshold of
about 35 for 10 copies of DNA per 5ml of sample. All of these
real-time PCRs have good sensitivity and specificity (Supple-
mentary Table 3). In total, 64 obese samples and 43 control
samples were analyzed. The presence of B. animalis was
associated with normal weight (Table 4, Fisher’s exact test,
P¼0.007), and L. reuteri was associated with obesity (Fisher’s
exact test, P¼0.03). Comparison using non-parametric
statistics found that levels of B. animalis were lower
(Mann–Whitney test, P¼0.004) and that of L. reuteri were
higher in obese people (Mann–Whitney test, P¼0.02)
(Figure 3). By comparing the culture and the Lactobacillus
species-specific PCR, the sensitivity was higher for all seven
tested species by PCR vs culture except for L. acidophilus,
which was not found by culture or species-specific PCR.
Overall, results of culture and PCR were consistent for the
presence of L. casei/paracasei (Fisher’s exact test, P¼0,017),
L. plantarum (Fisher’s exact test, P¼0,05) and L. reuteri
(Fisher’s exact test, P¼0,00001).
Logistic regression analysis
The results of the logistic regression analysis on the qPCR
results are presented in Table 5. Variables eligible for the final
model were L. casei/paracasei, L. reuteri, L. gasseri, B. animalis,
M. smithii and age. The final multiple logistic regression
model showed that after adjustment for age, L. reuteri,
B. animalis and M. smithii were significantly associated with
Figure 1 Quantification of L. paracasei, L. plantarum and L. reuteri in culture (LAMVAB medium)  log (colony forming units per ml of feces)FMann–Whitney test.
Table 3 Results of Bacteroidetes, Firmicutes, Methanobrevibacter smithii and
Lactobacillus genus quantitative PCR
Obese (n¼67) Controls (n¼45) P
Presence of phyla, genus or species
a
Bacteroidetes 41 (61.2%) 27 (60%) 0.52
Firmicutes 67 (100%) 45 (100%) F
Lactobacillus 23 (34.3%) 8 (17.8%) 0.04
Methanobrevibacter smithii 50 (74.6%) 40 (88.9%) 0.05
Quantitative comparison (log copies DNAml
 1)
b
Bacteroidetes 4.26 (0–5.82) 5.65 (0–6.37) 0.25
Firmicutes 6.43 (5.32–7.29) 6.62 (5.86–7.21) 0.30
Lactobacillus 0 (0–3.31) 0 (0–0) 0.039
Methanobrevibacter smithii 2.31 (0–3.51) 3.78 (1.71–5.30) 0.002
aValues noted as number (percentage), Fisher’s exact test.
bValues noted as
log copies DNAml
 1, median (interquartile range), Mann–Whitney test.
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levels in obese individuals while B. animalis and M. smithii
were found at greater levels in non-obese subjects.
Discussion
To our knowledge, we report the largest case–control study
comparing human obese gut microbiota to controls focusing
on Archaea, Bacteroidetes, Firmicutes, Lactobacillus genus,
Lactococcus lactis and B. animalis and, for the first time, we
used a culture-dependent and culture-independent method
to compare the Lactobacillus population at the species level
between obese and normal-weighted humans. Our results
confirm global alteration in obese gut microbiota with a
lower level of M. smithii as already reported in the
literature,
11 and newly report lower levels of B. animalis,
L. paracasei, L. plantarum and higher levels of L. reuteri in
obese gut microbiota.
The qPCR system used in this study to detect and quantify
Bacteroidetes, Firmicutes, Lactobacillus genus and M. smithii in
human feces has already been evaluated and validated.
12,29
LAMVAB-selective media has also been used successfully to
Figure 2 Quantification of Bacteroidetes, Firmicutes, M. smithii and Lactobacillus genus by qPCRFMann–Whitney test.
Table 4 Results of Bifidobacterium animalis, Lactococcus lactis and seven
Lactobacillus species-specific quantitative PCR
Obese (n¼64) Controls (n¼43) P
Presence of targeted taxa
a
L. acidophilus 0 (0%) 0 (0%) F
L. casei/paracasei 24 (37.5%) 24 (55.8%) 0.047
L. fermentum 11 (17.2%) 9 (20.9%) 0.40
L. gasseri 21 (32.8%) 9 (20.9%) 0.13
L. plantarum 14 (21.9%) 12 (27.9%) 0.31
L. reuteri 16 (25.0%) 4 (9.3%) 0.03
L. rhamnosus 11 (17.2%) 9 (20.9%) 0.40
Lactococcus lactis 55 (85.9%) 34 (79.1%) 0.25
Bifidobacterium animalis 1 (1.6%) 7 (16.3%) 0.007
aValues expressed as number (percentage). Fisher’s exact test.
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27 As
in our previous study,
12 we found an increase in Lactobacillus
in obese patients using the same Lactobacillus genus-specific
PCR system. However, we found that its sensitivity profile
was heterogeneous among the Lactobacillus species found in
human feces by culture (data not shown). We subsequently
developed a novel Lactobacillus species-specific qPCR system
targeting species associated with obesity or normal weight in
our preliminary culture study, and targeting other species
present in marketed probiotics products as Lactococcus lactis
and B. animalis. Species-specific Lactobacillus PCR based
on the Tuf gene and designed for this new study showed
good reproducibility, sensitivity and specificity. However,
we found significant discrepancies between culture and
Lactobacillus species-specific PCR species. First, L. gasseri
and L. acidophilus could not be identified in culture due
to the presence of vancomycin in the LAMVAB medium.
Conversely, although qPCR was much more sensitive than
culture to detect selected species of Lactobacillus, we showed
that the two methods were consistent for L. casei/paracasei,
L. plantarum and L. reuteri. For these three Lactobacillus
species, both techniques resulted in the same effect direction
with human obesity gut microbiota enriched in L. reuteri,
and depleted in L. casei/paracasei and L. plantarum.
Figure 3 Quantification of B. animalis, L. casei/paracasei, L. plantarum and L. reuteri by qPCRFMann–Whitney test.
Table 5 Factors associated with obesity based on multiple logistic regression
(qPCR results, logistic regression analysis, n¼107)
OR (95%CI) P-value
Lactobacillus reuteri 1.79 (1.03–3.10) 0.04
Bifidobacterium animalis 0.63 (0.39–1.01) 0.056
Methanobrevibacter smithii 0.76 (0.59–0.97) 0.03
Age 1.05 (1.01–1.08) 0.006
Abbreviations: CI, confidence interval; OR, odds ratio; qPCR, quantitative PCR.
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alteration significantly associated with obesity as reported
by Ley and Turnbaugh,
8 in mice and in North American
individuals,
7,9 and by Santacruz et al.,
15 who observed
overweight pregnant women in Spain. We found the same
correlation in our previous study,
12 and the same effect
direction in the present study with the same PCR system on
the whole population and after the exclusion of common
subjects. Schwiertz et al.
11 reported opposite results, but the
methodology was objectionable because the Bacteroidetes
proportion was obtained by summing Bacteroides and
Prevotella genera. Other studies found no interaction
between the relative or absolute abundance of Bacteroidetes
and obesity.
31–33
In our previous study,
12 abundance of M. smithii was
significantly higher in patients with anorexia but not in
lean controls. In this new study, we found that M. smithii
was less frequent and significantly less abundant in obese
patients on the whole population and after the exclusion of
common subjects. Schwiertz et al.
11 using a specific qPCR for
Methanobrevibacter species, found similar results in a German
population. These results are in contradiction to those of
Zhang et al.
33 who found that Methanobacteriales was present
only in obese individuals using a qPCR but only three obese
vs three controls were compared.
In this study, we report an association between lower levels
of B. animalis and obesity for the first time. Five studies
reported a decreased number of Bifidobacterium representatives
in the feces of obese subjects at the genus level.
11,13–16 At the
species level, Kalliomaki et al.
13 using a Bifidobacterium species-
specific PCR, found that Bifidobacterium longum and Bifidobac-
terium breve were higher in normal weight controls, but this
result was not significant probably because of a small sample
size. Experimental data report that administration of a B. breve
strain to mice with high-fat diet-induced obesity led to a
significant weight decrease.
34 Administering four different
Bifidobacterium strains to high-fat diet induced obese rats, Yin
et al.
35 reported that one strain increased body weight gain,
another induced a decrease and the two other strains lead to no
significant change in body weight but species were not
mentioned in this study. In this way, Cani et al.
36 reported
that high-fat feeding was associated with higher endotoxaemia
and lower Bifidobacterium species cecal content in mice. The
selective increase of bifidobacteria by oligofructose, improving
mucosal barrier function, significantly and positively correlated
with improved glucose tolerance, glucose-induced insulin
secretion and decreased endotoxaemia.
L. plantarum and L. paracasei were associated with normal
weight in culture, consistent with experimental models in
the literature reporting an anti-obesity effect of L. plantarum
in mice.
37 Other Lactobacillus strains have shown an anti-
obesity effect in animals and humans similar to the L. gasseri
SBT2055 (LG2055) strain in lean Zucker rats
38 and in
humans.
39 This anti-obesity effect may be linked to the
production of specific molecules that can interfere with
host metabolism, such as conjugated linoleic acid (CLA) for
L. plantarum or L. rhamnosus.
37,40 In vivo and in vitro analyses
of physiological modifications imparted by CLA on protein
and gene expression suggest that CLA exerts its delipidating
effects by modulating energy expenditure, apoptosis, fatty
acid oxidation, lipolysis, stromal vascular cell differentia-
tion and lipogenesis.
37 Authors who have investigated the
mechanisms linking conjugated linoleic acid and anti-
obesity effects have reported the upregulated expression of
genes encoding uncoupling proteins (UCP-2), which could
be a primary mechanism through which CLA increases
energy expenditure and produces an anti-obesity effect.
40
L. reuteri has been associated here with obesity. L. reuteri
has been one of the most studied probiotic species especially
for its ability to inhibit the growth of other potentially
pathogenic microorganisms by secreting antibiotic sub-
stances such as reuterin.
41 When introduced in pigs, turkeys
and rats, L. reuteri led to a significant weight gain and was
isolated in higher concentrations from feces after probiotic
administration.
42–44 The mechanism by which L. reuteri is
able to support the healthy growth of these animals is not
entirely understood. It is possible that L. reuteri simply serves
to protect livestock against illness caused by Salmonella
typhimurium and other pathogens. However, other studies
have revealed that L. reuteri can also help when the growth
depression is caused entirely by a lack of dietary protein and
not by contagious disease.
45 This raises the possibility that
L. reuteri somehow improves the intestines’ ability to absorb
and process nutrients, and increase food conversion.
46
As a theoretical basis for the causal link between the
gut microbiota alterations and obesity, several mechanisms
have been suggested. First, the gut microbiota could inter-
act with weight regulation by hydrolysis of indigestible
polysaccharides to monosaccharides easily absorbable acti-
vating lipoprotein lipase. Consequently, glucose is rapidly
absorbed producing substantial elevations in serum glucose
and insulin, both factors that trigger lipogenesis and fatty
acids excessively stored with de novo synthesis of triglycerides
derived from liver, these two phenomena causing weight
gain.
47 Second, the composition of gut microbiota has been
shown to selectively suppress the angiopoietin-like protein
4/fasting-induced adipose factor in the intestinal epithelium,
known as a circulating lipoprotein lipase inhibitor and
regulator of peripheral lipid and glucose metabolism.
48
Third, it has been suggested that bacterial isolates of gut
microbiota may have pro- or anti-inflammatory properties,
impacting weight as obesity, having been associated with a
low-grade systemic inflammation corresponding to higher
plasma endotoxin lipopolysaccharide concentrations defined
as metabolic endotoxaemia.
49–52 Fourth, extracting crude fat
in feed and excreta, Nahashon et al.
53 reported that feeding
laying Leghorn with Lactobacillus improved significantly
retention of fat with increased cellularity of the Peyer’s
patches of the ileum, which indicated ileal immune response.
Conversely, Bifidobacterium and Lactobacillus species have
been cited to deconjugate bile acids, which may decrease
fat absorption.
54
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fed to farm animals have been shown to increase daily
weight gain,
55 and this fact has been used for decades in
agriculture to increase feed conversion. In this context, one
cannot exclude that the ‘growth promoter’ effect in animals
associated with oral administration of specific probiotics
strains is similar to the mechanisms involved in human
obesity. For instance, Abdulrahim et al.
56 reported that
L. acidophilus significantly increased abdominal fat deposi-
tion in female chickens when administered alone and up to
31% when it was associated with zinc bacitracin. Further
studies are therefore mandatory in exploring the interactions
between probiotics and weight regulation.
Conclusion
In conclusion, reduced levels of M. smithii has been
confirmed as being associated with obesity. In addition,
higher levels of B. animalis, L. paracasei or L. plantarum were
associated with a normal weight whereas higher levels of
L. reuteri were associated with obesity, suggesting a
possible interrelationship between certain probiotic species,
marketed elsewhere for human consumption, and obesity.
These results must be considered cautiously because it is the
first study to date that links specific species of Lactobacillus
with obesity in humans. This issue will be of critical
importance in the management of the twenty-first century
worldwide epidemic that is obesity and especially consider-
ing the booming market of probiotics.
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